Botanicals as medicinal food and their effects on drug metabolizing enzymes

Food and Chemical Toxicology

Volumn 49, Issue 12, 2011, Pages 3142-3153

  Mukherjee, Pulok K ^a   Ponnusankar, S ^a   Pandit, Subrata ^a   Hazam, Praksh K ^a   Ahmmed, Milan ^a   Mukherjee, Kakali ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

Botanicals; Cytochrome P450; Drug metabolizing enzymes; Herb drug interaction; Induction; Inhibition

Indexed keywords

ACORUS CALAMUS EXTRACT; AYURVEDIC DRUG; BOSWELLIA EXTRACT; CHAMOMILLA RECUTITA EXTRACT; CIMICIFUGA RACEMOSA EXTRACT; CYTOCHROME P450; DRUG METABOLIZING ENZYME; ECHINACEA PURPUREA EXTRACT; EVODIA FRUIT EXTRACT; EVODIA RUTAECARPA EXTRACT; GARDENIA JASMINOIDES EXTRACT; GINKGO BILOBA EXTRACT; HYDRASTIS CANADENSIS EXTRACT; KAVA EXTRACT; KETOCONAZOLE; PHYLLANTHUS AMARUS EXTRACT; PLANT EXTRACT; PUERARIA EXTRACT; QUINIDINE; TERMINALIA CHEBULA EXTRACT; THONNINGIA SANGUINEA EXTRACT; TOLBUTAMIDE; UNCLASSIFIED DRUG; VALERIAN; WARFARIN; ZINGIBER AROMATICUM EXTRACT;

BOSWELLIA; CIMICIFUGA RACEMOSA; CONCENTRATION RESPONSE; DRUG INHIBITION; ENZYME INDUCTION; ENZYME INHIBITION; EVODIA; EVODIA RUTAECARPA; GINGER; HERB DRUG INTERACTION; HUMAN; HYDRASTIS; INHIBITION KINETICS; MEDICINAL PLANT; NONHUMAN; PROTEIN FUNCTION; REVIEW; THONNINGIA SANGUINEA; ZINGIBER AROMATICUM;

CYTOCHROME P-450 ENZYME SYSTEM; HERB-DRUG INTERACTIONS; METABOLIC DETOXICATION, DRUG; NONPRESCRIPTION DRUGS; PHYTOTHERAPY; PLANTS, MEDICINAL; PRESCRIPTION DRUGS;

EID: 80054868726     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.09.015     Document Type: Review

References (61)

1. Budzinski J., Foster B.C., Vandenhoek S., Arnason J.T. An in vitro evaluation of human cytochrome (CYP3A4) inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 2000, 7:273-282.
2. Bent S., Goldberg H., Padula A., Avins A.L. Spontaneous bleeding associated with Ginkgo biloba. J. Gen. Intern. Med. 2005, 20(7):657-661.
3. Budzinski J.W., Arnason J.T., Trudeau V., Krantis A., Foster B.C. Effects of goldenseal and milk thistle on the modulation of cytochrome P4503A4 and P-glycoprotein. Drug Met. Rev. 2001, 33(S1):86.
4. Chatterjee P., Franklin M.R. Human cytochrome P450 inhibition and metabolic intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components. Drug Metab. Dispos 2003, 31:1391-1397.
5. Crespi C.L., Penman B.W. Use of cDNA expressed human cytochrome P450 enzymes to study potential drug-drug interactions. Adv. Pharmacol. 1997, 43:171-188.
6. Dhananjay P., Mitra A.K. MDR and CYP3A4 mediated drug-herbal interactions. Life Sci. 2006, 78:2131-2145.
7. Eagling V.A., Profit L., Back D. Inhibition of the CYP3A4 mediated metabolism and P-glycoprotein mediated transport of the HIV- 1 protease inhibitor saquinavir by grapefruit juice components. Br. J. Clin. Pharmacol. 1999, 48:543-552.
8. Foster B.C., Vandenhoek S., Hana J., Krantis A., Akhtar M.H., Bryan M., Budzinski J.W., Ramputh A., Arnason J.T. In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products. Phytomedicine 2003, 10:334-342.
9. Frank A., Unger M. Analysis of frankincense from various Boswellia species with inhibitory activity on human drug metabolizing cytochrome P450 enzymes using liquid chromatography mass spectrometry after automated on-line extraction. J. Charomatogr. A 2006, 21:255-262.
10. Fugh-Berman A. Herb-drug interactions. Lancet 2000, 355:134-138.
11. Fugh-Berman A., Ernst E. Herb-drug interactions: review and assessment of report reliability. Br. J. Clin. Pharmacol. 2001, 52:587-595.
12. Ganzera M., Schneider P., Stuppner H. Inhibitory effects of the essential oil of chamomile (Matricaria recutita L.) and its major constituents on human cytochrome P450 enzymes. Life Sci. 2006, 78:856-861.
13. Greenblatt D.J., Von Moltke L.L., Luo Y., Perloff E.S., Horan K.A., Bruce A., Reynolds R.C., Harmatz J.S., Avula B. Ginkgo biloba does not alter clearance of flurbiprofen, a cytochrome P4502C9 substrate. J. Clin. Pharmacol. 2006, 46:214-221.
14. Guerra M.C., Speroni E., Broccoli M., Cangini M., Pasini P., Minghetti A., Crespi N., Mirasoli M., Cantelli F.G., Paolini M. Comparison between Chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin antioxidant properties and effects on rat liver CYP catalyzed drug metabolism. Life Sci. 2000, 67:2997-3006.
15. Gurley B.J., Gardner S.F., Hubbard M.A., Williams D.K., Gentry W.B., Carrier J., Khan I.A., Edwards D.J., Shah A. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. Clin. Pharmacol. Ther. 2004, 76:428-440.
16. Gurley B.J., Gardner S.F., Hubbard M.A., Williams K., Gentry W.B., Khan I.A., Shah A. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P4501A2, 2D6, 2E1, and 3A4 phenotypes. Clin. Pharmacol. Ther. 2005, 77:415-426.
17. Gyamfi M.A., Hokama N., Oppong-Boachie K., Aniya Y. Inhibitory effects of the medicinal herb Thonningia sanguine on liver drug metabolizing enzymes of rats. Human Exp. Toxicol. 2000, 19:623-631.
18. Gyamfi M.A., Yonamine M., Aniya Y. Free-radical scavenging action of medicinal herbs from Ghana: Thonningia sanguinea on experimentally-induced liver injuries. Gen. Pharmacol. 1999, 32:661-667.
19. Hansen T.S., Nilsen O.G. In vitro CYP3A4 metabolism: inhibition by Echinacea purpurea and choice of substrate for the evaluation of herbal inhibition. Basic Clin. Pharmacol. Toxicol. 2008, 103:445-449.
20. Harikumar K.B., Kuttan R. Inhibition of drug metabolizing enzymes (cytochrome P450) in vitro as well as in vivo by Phyllanthus amarus Schum and Thonn. Biol. Pharm. Bull. 2006, 29:1310-1313.
21. Iwata H., Tezuka Y., Kadota S., Hiratsuka A., Watabe T. Mechanism based inactivation of human liver microsomal CYP3A4 by rutaecarpine and limonin from Evodia fruit extract. Drug Metab. Pharmacokinet. 2005, 20:34-45.
22. Izzo A.A., Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 2001, 61:2163-2175.
23. Jennifer A., Ramzan I. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. F). J. Ethnopharmacol. 2004, 93:153-160.
24. Kalra B.S. Cytochrome P450 enzyme isoforms and their therapeutic implications: an update. Indian J. Med. Sci. 2007, 61:102-116.
25. Kang J.J., Wang H.W., Liu T.Y., Chen Y.C., Ueng T.H. Modulation of cytochrome P450 dependent monooxygenases, gluthathione and glutathione S-transferase in rat liver by geniposide from Gardenia jasminoides. Food Chem. Toxicol. 1997, 35:957-965.
26. Lefebvre T., Foster B.C., Drouin C.E., Krantis A., Arnason J.T., Livesey J.F., Jordan S.A. In vitro activity of commercial valerian root extracts against human cytochrome 3A4. J. Pharm. Pharmaceut. Sci. 2004, 7:265-273.
27. Lim S.T.S., Dragull K., Tang C., Bitternbender H.C., Efird J.T., Nerukar P.V. Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats. Toxicol. Sci. 2007, 97:214-221.
28. Liu K.H., Kim M.J., Jeon B.H., Shon J.H., Cha I.J., Cho K.H., Lee S.S., Shin J.G. Inhibition of human cytochrome P450 isoforms and NADPH-CYP reductase in vitro by 15 herbal medicines including Epimedii herba. J. Clin. Pharm. Ther. 2006, 31:83-91.
29. Maliakal P.P., Wanwimilruk S. Effect of herbal teas on hepatic drug metabolizing enzymes in rats. J. Pharm. Pharmacol. 2001, 53:1323-1329.
30. Manach C., Donovan L. Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radic Res. 2004, 38:771-785.
31. Marowitz J.S., DeVane C.L., Boulton D.W., Carson S.W., Nahas Z., Risch S.C. Effect of St. John's Wort (Hypericum perforatum) on cytochrome P4502D6 and 3A4 activity in healthy volunteers. Life Sci. 2000, 66:L133-L139.
32. Mathews J.M., Etheridge A.S., Black S.R. Inhibition of human cytochrome P450 activities by kava extract and kavalactones. Drug Metab. Dispos. 2002, 30:1153-1157.
33. Modarai M., Gertsch J., Suter A., Heinrich M., Kortenkamp A. Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content. J. Pharm. Pharmacol. 2007, 59:567-573.
34. Modarai M., Silva E., Suter A., Heinrich M., Kortenkamp A. Safety of herbal medicinal products: Echinacea and selected alkylamides do not induce cyp3a4 mRNA expression. eCAM 2009, 1-7.
35. Mukherjee P.K. Problems and prospects for the GMP in herbal drug in Indian system of medicine. Drug Inf. J. 2002, 63:635-644.
36. Mukherjee P.K. Exploring botanicals in Indian system of medicine - regulatory perspectives. Clin. Res. Reg. Affairs 2003, 20:249-264.
37. Mukherjee P.K. Evaluation of Indian traditional medicine. Drug Inf. J. 2004, 35:623-632.
38. Mukherjee P.K., Rai S., Bhattacharya S., Wahile A., Saha B.P. Marker analysis of polyherbal formulation, Triphala-a well known Indian traditional medicine. Indian J. Trad. Know. 2008, 7:379-383.
39. Mukherjee P.K., Rai S., Kumar V., Mukherjee K., Hylands P.J., Hider R.C. Plants of Indian origin in drug discovery. Expert Opin. Drug Discov. 2007, 2:633-657.
40. Mukherjee P.K., Wahile A. Integrated approaches towards drug development from Ayurveda and other Indian system of medicines. J. Ethnopharmacol. 2006, 103:25-35.
41. Pan Y., Abd-Rashid B.A., Ismail Z., Ismail R., Mak J.W., Pook P.C., Er H.M., Ong C.E. In vitro modulatory effects on three major human cytochrome P450 enzymes by multiple active constituents and extracts of Centella asiatica. J. Ethnopharmacol. 2010, 130(2):275-283.
42. Pandit S., Mukherjee P.K., Ponnusankar S., Venkatesh M., Srikanth N. Metabolism mediated interaction of α-asarone and Acorus calamus with CYP3A4 and CYP2D6. Fitoterapia 2011, 82(3):369-374.
43. Ponnusankar S., Pandit S., Babu R., Bandyopadhyay A., Mukherjee P.K. Cytochrome P450 inhibitory potential of Triphala - a rasayana from Ayurveda. J. Ethnopharmacol. 2011, 133:120-125.
44. Ponnusankar S., Pandit S., Venkatesh M., Bandyopadhyay A., Mukherjee P.K. Safety evaluation of standardized extract of Terminalia chebula Retz by Cytochrome P450 inhibition assay. Phytother. Res. 2011, 25(1):151-154.
45. Scott L.M., Leduc R.I., Burt A.J., Marles R.J., Arnason J.T., Foster B.C. The inhibition of human cytochrome P450 by ethanol extracts of North American botanicals. Pharm. Biol. 2006, 44:315-327.
46. Strandell J., Neil A., Carlin G. An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies. Phytomedicine 2004, 11:98-104.
47. Takanaga H., Ohnishi A., Murakami H., Matsuo H., Higuchi S., Urae A., Irie S., Furuie H., Matsukuma K., Kimura M., Kawano K., Orii Y., Tanaka T., Sawada Y. Relationship between time after intake of grapefruit juice and the effect of pharmacokinetics and pharmacodynamics on nisoldipine in healthy subjects. Clin. Pharmacol. Ther. 2000, 37:201-214.
48. Tirona R.G., Bailey D.G. Herbal product-drug interactions mediated by induction. Br. J. Clin. Pharmacol. 2006, 61:677-681.
49. Tsukamoto S., Aburatani M., Tomihisa O. Isolation of CYP3A4 inhibitors from Black Cohosh (Cimicifuga racemosa). eCAM 2005, 2:223-226.
50. Tsukamoto S., Aburatani M., Yoshida T., Yamashita Y., El-Beih A.A., Ohta T. CYP3A4 inhibitors isolated from Licorice. Biol. Pharm. Bull. 2005, 28:2000-2002.
51. Uchida S., Yamada H., Li X.D., Maruyama S., Ohmori Y., Oki T., Watanabe H., Umegaki K., Ohashi K., Yamada S. Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers. J. Clin. Pharmacol. 2006, 46:1290-1298.
52. Ueng Y.F., Ko H.C., Chen C.F., Wang J.J., Chen K.T. Modulation of drug metabolizing enzymes by extracts of a herbal medicine Evodia rutaecarpa in C57BL/6J mice. Life Sci. 2002, 71:1267-1277.
53. Unger M., Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun. Mass Spectrom. 2004, 18:2273-2281.
54. Unger M., Holzgrabe U., Jacobsen W., Cummins C., Benet L.Z. Inhibition of cytochrome P4503A4 by extracts and kavalactones of Piper methysticum (kava kava). Plant Med. 2002, 68:1055-1058.
55. Usia T., Iwata H., Hiratsuka A., Watabe T., Kadota S., Tezuka Y. CYP3A4 and CYP2D6 inhibitory activities of Indonesian medicinal plants. Phytomedicine 2006, 13:67-73.
56. Usia T., Iwata H., Hirstsuk A., Watabe T., Kadota S., Tezuka Y. Sesquiterpenes and flavonol glycosides from Zingiber aromoaticum and their CYP3A4 and CYP2D6 inhibitory activities. J. Nat. Prod. 2004, 67:1079-1083.
57. Usia T., Watabe T., Kadota S., Tezuka Y. Mechanism based inhibition of CYP3A4 by constituents of Zingiber aromaticum. Biol. Pharm. Bull. 2005, 28:495-499.
58. von Moltke L.L., Weemhoff J.L., Bedir E., Khan I.A., Harmatz J.S., Goldman P., Greenlatt D.J. Inhibition of human cytochrome P450 by components of Ginkgo biloba. J. Pharm. Pharmacol. 2004, 56:1039-1044.
59. WHO Traditional Medicine Strategy 2002-2005, 2002. World Health Organization Document, WHO/EDM/TRM/2002.1. World Health Organization, Geneva.
60. Zhou S., Gao Y., Jiang W., Huang M., Xu A., Paxton J.W. Interactions of herbs with cytochrome P450. Drug Metabol. Rev. 2003, 35:35-98.
61. Zou L., Harkey M.R., Henderson G.L. Effects of herbal components of cDNA expressed cytochrome P450 enzyme catalytic activity. Life Sci. 2002, 71:1579-1589.